PNLIP and obesity due to melanocortin 4 receptor deficiency: Thus, a relevant source of plant phenolics, as potential therapeutic agents that can be used to decrease blood glucose levels and lipids for the dual control of diabetes and obesity via digestive enzyme inhibition, specifically pancreatic α-amylase, intestinal β-glucosidase and pancreatic lipase inhibition [15], along with its ability to boost the body’s antioxidant system, has become an absolute necessity.